Search for:
Avacta Life Sciences Limited
About
Therapeutics
Diagnostics
Diagnostics
Products
Affimer
®
Key benefits
Partnering
Resources
News
Investors
News
Careers
Contact
About
About Avacta
People
Scientific Resources
Intellectual Property
Virtual tour
Therapeutics
Therapeutics
Affimer
®
pre
CISION
TM
Pipeline
Partnering
Clinical trials
News
Diagnostics
Diagnostics
Products
Affimer
®
Key benefits
Partnering
Resources
News
Investors
Investors
CEO Welcome
Key information
Corporate Governance
Documents & Presentations
Share price
RNS News
News
Careers
CEO Welcome
Job vacancies
About Avacta
Benefits of working at Avacta
Contact
About
About Avacta
People
Scientific Resources
Intellectual Property
Virtual tour
Therapeutics
Therapeutics
Affimer
®
pre
CISION
TM
Pipeline
Partnering
Clinical trials
News
Diagnostics
Diagnostics
Products
Affimer
®
Key benefits
Partnering
Resources
News
Investors
Investors
CEO Welcome
Key information
Corporate Governance
Documents & Presentations
Share price
RNS News
News
Careers
CEO Welcome
Job vacancies
About Avacta
Benefits of working at Avacta
Contact
Home
Diagnostics
Diagnostic Resources
Diagnostic Resources
Application Notes
Affimer® binders improve diagnostic assay performance for C.difficile detection
Rapid identification and characterisation of Zika NS1 specific Affimer® binders
Validation of the AffiDX® SARS-CoV-2 Antigen Lateral Flow Test for the Detection of the Delta Variant of Concern
Posters
Affimer® Proteins – Next Generation Affinity Tools
Turning a Negative to a Positive with Anti-metatype Affimer® Reagents
Rapid Development of anti-SARS CoV-2 Spike S1 Affimer® Reagents for Diagnostic Applications
White papers
Affimer® binders for affinity applications: Introduction and key feature comparison
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok